AstraZeneca Inks R&D Deal With Ramaswamy's Roivant for Hush-Hush Indication Post author:Sam Post published:October 18, 2017 Post category:BioPharma Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra. Source: BioSpace You Might Also Like Regeneron Keeps Science at the Center January 16, 2018 Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017 DNAnexus Announces Two Key Executive Appointments March 15, 2017
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations August 31, 2017